|
Volumn 22, Issue 8, 2002, Pages 2663-2672
|
Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
RETINOBLASTOMA PROTEIN;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR E2F;
TRANSCRIPTION FACTOR E2F1;
TRANSCRIPTION FACTOR E2F3;
UNCLASSIFIED DRUG;
ALLELE;
ANIMAL TISSUE;
ARTICLE;
CANCER INHIBITION;
CARCINOGENESIS;
CONGESTIVE HEART FAILURE;
CONTROLLED STUDY;
DEVELOPMENTAL DISORDER;
DISEASE EXACERBATION;
EMBRYO;
EMBRYO DEVELOPMENT;
GENE EXPRESSION;
GENE LOSS;
GROWTH RETARDATION;
IN VIVO STUDY;
INCIDENCE;
MOUSE;
MOUSE STRAIN;
MUTANT;
MUTATION;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
AGING;
ANIMALS;
ANIMALS, NEWBORN;
CELL CYCLE PROTEINS;
DNA-BINDING PROTEINS;
E2F TRANSCRIPTION FACTORS;
E2F1 TRANSCRIPTION FACTOR;
E2F3 TRANSCRIPTION FACTOR;
EMBRYONIC AND FETAL DEVELOPMENT;
FEMALE;
HEART FAILURE, CONGESTIVE;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, KNOCKOUT;
MICE, MUTANT STRAINS;
MODELS, CARDIOVASCULAR;
NEOPLASMS, EXPERIMENTAL;
PHENOTYPE;
TRANSCRIPTION FACTORS;
ANIMALIA;
|
EID: 0036205327
PISSN: 02707306
EISSN: None
Source Type: Journal
DOI: 10.1128/MCB.22.8.2663-2672.2002 Document Type: Article |
Times cited : (77)
|
References (60)
|